USA-based generics major Mylan (Nasdaq: MYL) and health care firm Abbott Laboratories (NYSE: ABT) this morning confirmed they have entered into a definitive agr 14 July 2014
US generics and specialty drugmaker Mylan (NYSE: MYL) $1.6-billion foreign direct investment proposal - aiming to acquire Indian pharma firm Strides Arcolab's ( 22 August 2013
Privately-held US generic drugmaker Breckenridge Pharmaceutical has entered into an agreement to acquire from Pernix Therapeutics (NYSE: PTX) certain assets fro 12 August 2013
USA-based Insmed (NASDAQ CM: INSM) is a biopharmaceutical company on the development and commercialization of novel, targeted inhaled therapies for patients with serious rare diseases.
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news